Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2008
The purpose of this study is to evaluate the immunogenicity and reactogenicity of various formulations of recombinant hepatitis B vaccine with different adjuvants in healthy adult volunteers following the 0, 1, 6 months schedule
Epistemonikos ID: 914359739eb7d8a068e385994d15d711b3589f65
First added on: Nov 24, 2021